Skip to main content
OpenTrials

Clinical trial condition

Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Explore clinical trials studying Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

14 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trial results

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT06589804

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
View all 192 locations
View Trial Details
Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT06980038

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +41 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Ochsner Medical Center Jefferson New Orleans, Louisiana, United States
View Trial Details
Recruiting

Oropharynx (OPX) Biomarker Trial

NCT06356272

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +29 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions